BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 12012963)

  • 21. [Meningococcal disease in Africa--epidemiology and prevention].
    Norheim G; Rosenqvist E; Aavitsland P; Caugant DA
    Tidsskr Nor Laegeforen; 2000 Jun; 120(15):1735-9. PubMed ID: 10904659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.
    LaForce FM; Djingarey M; Viviani S; Preziosi MP
    Hum Vaccin Immunother; 2018 May; 14(5):1098-1102. PubMed ID: 28968148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Which vaccination strategies for African meningococcal meningitis?].
    Saliou P; Debois H
    Bull Soc Pathol Exot; 2002 Dec; 95(5):326-30. PubMed ID: 12696369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.
    Marc LaForce F; Ravenscroft N; Djingarey M; Viviani S
    Vaccine; 2009 Jun; 27 Suppl 2():B13-9. PubMed ID: 19477559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidemiological and control aspects of meningococcal meningitis epidemics in Africa].
    Spiegel A; Moren A; Varaine F; Baudon D; Rey M
    Sante; 1994; 4(3):231-6. PubMed ID: 7921694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy.
    Leake JA; Kone ML; Yada AA; Barry LF; Traore G; Ware A; Coulibaly T; Berthe A; Mambu Ma Disu H; Rosenstein NE; Plikaytis BD; Esteves K; Kawamata J; Wenger JD; Heymann DL; Perkins BA
    Bull World Health Organ; 2002; 80(5):342-9. PubMed ID: 12077608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meningitis epidemics in Africa: a brief overview.
    Teyssou R; Muros-Le Rouzic E
    Vaccine; 2007 Sep; 25 Suppl 1():A3-7. PubMed ID: 17643560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa.
    Robbins JB; Towne DW; Gotschlich EC; Schneerson R
    Lancet; 1997 Sep; 350(9081):880-2. PubMed ID: 9310615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tetravalent anti-meningococcal vaccine: serologic and clinical evaluation].
    Vescia N; Mastroeni I; Pompa MG; Signorelli C; Fara GM
    Ann Ig; 1989; 1(6):1293-8. PubMed ID: 2484465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neisseria meningitidis: new vaccines and preventive strategies].
    Morciano L; Zaratti L; Franco E
    Ig Sanita Pubbl; 2012; 68(1):97-104. PubMed ID: 22507995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The changing epidemiology of meningococcal meningitis after introduction of bivalent A/C polysaccharide vaccine into school-based vaccination programs in Egypt.
    Nakhla I; Frenck RW; Teleb NA; El Oun S; Sultan Y; Mansour H; Mahoney F
    Vaccine; 2005 May; 23(25):3288-93. PubMed ID: 15837234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward a meningitis-free world.
    Black S; Pizza M; Nissum M; Rappuoli R
    Sci Transl Med; 2012 Feb; 4(123):123ps5. PubMed ID: 22378923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of emerging vaccines for childhood meningococcal disease.
    Choudhuri D; Huda T; Theodoratou E; Nair H; Zgaga L; Falconer R; Luksic I; Johnson HL; Zhang JS; El Arifeen S; Nelson CB; Borrow R; Campbell H; Rudan I
    BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S29. PubMed ID: 21501447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental strategy for a new Group A meningococcal conjugate vaccine (MenAfriVac
    Kulkarni PS; Jadhav SS; LaForce FM
    Hum Vaccin Immunother; 2018 May; 14(5):1103-1106. PubMed ID: 29048988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial meningitis. Appeal to thwart deadly outbreak.
    Vogel G
    Science; 2002 Oct; 298(5592):339. PubMed ID: 12376673
    [No Abstract]   [Full Text] [Related]  

  • 36. Vaccine offers meningitis hope.
    Butler D
    Nature; 2010 Nov; 468(7321):143. PubMed ID: 21068797
    [No Abstract]   [Full Text] [Related]  

  • 37. Critical episodes in the understanding and control of epidemic meningococcal meningitis.
    Artenstein AW; LaForce FM
    Vaccine; 2012 Jun; 30(31):4701-7. PubMed ID: 22525794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemic meningitis control in countries of the African meningitis belt, 2016.
    Wkly Epidemiol Rec; 2017 Mar; 92(13):145-54. PubMed ID: 28361528
    [No Abstract]   [Full Text] [Related]  

  • 39. Technical Development of a New Meningococcal Conjugate Vaccine.
    Frasch CE; Kapre SV; Lee CH; Préaud JM
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S404-9. PubMed ID: 26553667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global epidemiology of meningococcal disease.
    Harrison LH; Trotter CL; Ramsay ME
    Vaccine; 2009 Jun; 27 Suppl 2():B51-63. PubMed ID: 19477562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.